Genomic analyses point to the potential of personalized care for liver cancer patients

A new study shows that by using genomic analyses to understand how and when carcinogenic mutations occur in patients with hepatocellular carcinoma, it is possible to identify specific molecular profiles. It is hoped that these molecular profiles will help identify which patients would benefit from specific anticancer treatments.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1OQQgP7